Top compounds associated with response to ELAVL4


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.24 7e-08
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.34 7e-08
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.21 9e-08
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.21 3e-07
mRNA FK866 GDSC1000 pan-cancer AAC 0.2 4e-07
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.22 6e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 6e-07
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.2 6e-07
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.25 7e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 8e-07
Download CSV